Food and Drugs Act, R.S.C. 1985, c. F-27
Section 31.4
Offences — section 21.6 and serious risk
Cite as Food and Drugs Act, R.S.C. 1985, c. F-27, s. 31.4 · current to July 24, 2025 · Act last amended March 27, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) A person who contravenes section 21.6, or who knowingly or recklessly causes a serious risk of injury to human health in contravening another provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable
(a) on conviction on indictment, to a fine the amount of which is at the discretion of the court or to imprisonment for a term not exceeding five years or to both; and
(b) on summary conviction, for a first offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both and, for a subsequent offence, to a fine not exceeding $1,000,000 or to imprisonment for a term not exceeding two years or to both.
(2) For greater certainty, subsection (1) applies in respect of the following provisions of this Act:
(a) section 3, if the contravention of that section involves a therapeutic product;
(a.1) section 3.1, if the contravention of that section involves a clinical trial that relates to a therapeutic product;
(a.2) section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to a therapeutic product;
(b) subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to a therapeutic product or a sample that is or relates to a therapeutic product;
(c) subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;
(d) subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;
(e) subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to a therapeutic product;
(f) subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to a therapeutic product; and
(g) subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to a therapeutic product.
Read the Food and Drugs Act on the Justice Laws Website ↗
Bills in Parliament that would change this section 1
- C-97 An Act to implement certain provisions of the budget tabled in Parliament on March 19, 2019 and other measures Amends s. 31.4 · 42nd Parliament, 1st session